Results 211 to 220 of about 3,729,717 (272)

Systemic vascular pooling potency of vasodilator drugs (nitroglycerin, phentolamine, hydralazine)

American Heart Journal, 1979
B. E. Strauer, A. Scherpe
openalex   +4 more sources

Oral nitroglycerin as a prophylactic antianginal drug: clinical, physiologic, and statistical evidence of efficacy based on a three-phase experimental design.

American Heart Journal, 1975
T. Winsor, T. Winsor, H. Berger, H. Berger   +3 more
semanticscholar   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

[Effect of drug-induced vasodilatation of basal brain arteries with nitroglycerin on blood flow velocity and volume flow in the middle cerebral artery].

Ultraschall in der Medizin, 2008
AIM The Müller-Casty flow index (FI) is recommended for use in transcranial Doppler sonography (TCD) to measure relative changes in volume flow. We examined the ability of the FI to assess the volume flow during diameter changes of basal cerebral ...
L. Niehaus, S. Gottschalk, U. Weber
semanticscholar   +1 more source

Transdermal Drug Delivery Systems (TDDS): Recent Advances and Failure Modes.

Molecular Pharmaceutics
Transdermal drug delivery systems (TDDS), commonly refered to as "patches", present a nonintrusive technique to provide medication without the need for invasive procedures.
Mohsen Ghaferi, S. Alavi, Khanh Phan, H. Maibach, Y. Mohammed   +4 more
semanticscholar   +1 more source

Current Status of Nitroglycerin Ointment in Angina Pectoris: a New Look At an Old Drug

Angiology, 1977
J. Abrams
semanticscholar   +4 more sources

Pulsed release of nitroglycerin from transdermal drug delivery systems

International Journal of Pharmaceutics, 1999
To achieve a discontinuous drug delivery to the skin a new actively controlled transdermal system has been developed. The system consists of a tube shaped drug reservoir in combination with an electronic circuit and a gas producing cell. A magnetic switch was used to control the onset of the production of hydrogen gas.
R. Gröning, U Kuhland
openaire   +3 more sources

A New Topical Drug Delivery System for Nitroglycerin

1981
Nitroglycerin has been the agent of choice for the treatment of angina pectoris for over 100 years. In recent years various long-acting preparations have been introduced for the prophylaxis of angina pectoris and most recently for use in the long term management of a patient with left ventricular dysfunction.
J. Brymer, A. Golub, J. Walton, A. Keith, B. Lucchesi, H. Colfer, P. Stetson, B. Pitt   +7 more
openaire   +2 more sources

Three-layer sandwich-like drug-loaded nanofibers of insulin, titanium oxide Nanotubes and Nitroglycerin as a promising wound healing candidate

Materials Chemistry and Physics, 2022
Hafez Raei, M. Jahanshahi, H. Morad
semanticscholar   +1 more source

Mechanisms of Respiratory Responses to Vasodilator Drugs Urecholine (Carbaminoyl Beta-Methylcholine) and Nitroglycerine

American Journal of Physiology-Legacy Content, 1957
The effects on respiratory rate and amplitude following intravenous injection of the vasodilator drugs, Urecholine (carbaminoyl-beta-methylcholine) and nitroglycerine were determined in dogs before and after bilateral vagotomy and isolation of the carotid sinuses.
William B. Youmans, Robert T. Schopp, Thomas M. Gilfoil   +2 more
openaire   +3 more sources

Cardiovascular Drugs: From Nitroglycerin to Lipitor

2006
Cardiovascular diseases are the leading cause of death worldwide and are projected to remain in the lead through 2025. Heart-related diseases include angina, arrhythmia, atrial fibrillation, congestive heart failure, hypertension, atherosclerosis, myocardial infarction (heart attack), and sudden cardiac death.
openaire   +1 more source